You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In a filing with the US Securities and Exchange Commission this week, Precipio said it had amended and restated an earlier securities purchase agreement with investors.
Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.
In Genome Research this week: a physical and genetic map of Cannabis sativa, evaluation of family- and population-based imputation tools, and more.
With a DNA methylation atlas and deconvolution algorithm, researchers are attempting to trace cfDNA back to tissue sources in healthy or ill individuals.
The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.
In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.
The Fertilome test, a multigene sequencing panel, assesses a number of markers that have been associated with conditions that affect fertility.
In an opinion piece at the Guardian, the National History Museum's Michael Dixon says the removal of Darwin and evolution from school curriculum is worrisome.
The deal will join CGI's portfolio of cancer tests and lab services with NovellusDx's technologies for cancer treatment response prediction.
The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine.
The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.
The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.
In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.